Profile and investment
| Fund type | Open Ended Investment Company |
|---|---|
| Investment style (stocks) | Market Cap: Large Investment Style: Blend |
| Morningstar category | Foreign Large Blend |
| Launch date | 29 May 2015 |
| Price currency | USD |
| Domicile | United States |
| Symbol | IEAIX |
| Manager & start date | Craig Scholl 29 May 2015 Susanne Willumsen 29 May 2015 Paul Moghtader 29 May 2015 Taras Ivanenko 29 May 2015 Ciprian Marin 29 May 2015 Alex Lai 01 May 2019 |
| Pricing frequency | Daily |
|---|---|
| Total net assets | 20.85m USD As of Mar 31 2024 |
| Share class size | 3.66m USD As of Mar 31 2024 |
| Net expense ratio | 0.80% |
| Front end load | -- |
| Deferred load | -- |
| Maximum Redemption Fee | -- |
| Min. initial investment | 10,000.00 USD |
| Min. additional investment | 50.00 USD |
| Initial IRA | -- |
| Additional IRA | -- |
| Available for sale | United States |
More ▼
Top 5 holdings
| Top 5 holdings as a per cent of portfolio | |||
|---|---|---|---|
| 15.72% | 12.09% | 0.00% | 12.09% |
| Category average | % Net assets | % Short | % Long |
| Company | 1 year change | Portfolio weight | Long allocation |
|---|---|---|---|
| Novo Nordisk A/S NOVO B:CPH | +51.46% | 3.21% | |
| ASML Holding NV ASML:AEX | +45.30% | 2.75% | |
| GSK plc GSK:LSE | +17.88% | 2.29% | |
| State Bank of India SBID:LSE | +42.45% | 2.04% | |
| Manulife Financial Corp MFC:TOR | +23.53% | 1.80% | |
| Per cent of portfolio in top 5 holdings: 12.09% |
Asset type
| Non-US stock | 98.45% |
| US stock | 0.78% |
| Cash | 0.68% |
| US bond | 0.00% |
| Non-US bond | 0.00% |
| Other | 0.09% |
Top 5 sectors
| Financial Services | 21.09% |
| Technology | 18.95% |
| Industrials | 15.12% |
| Consumer Cyclical | 13.11% |
| Healthcare | 11.84% |
| Other | 18.95% |
Top 5 regions
| Eurozone | 21.50% |
| Japan | 15.29% |
| Emerging Asia | 13.94% |
| Europe - ex Euro | 10.82% |
| Developed Asia | 10.73% |
| Other | 26.94% |
Sector and region weightings are calculated using only long position holdings of the portfolio.
